Pharmacological targeting of the protein synthesis mTOR/4E‐ BP 1 pathway in cancer‐associated fibroblasts abrogates pancreatic tumour chemoresistance
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
Pharmacological targeting of the protein synthesis mTOR/4E‐ BP 1 pathway in cancer‐associated fibroblasts abrogates pancreatic tumour chemoresistance ; volume:7 ; number:6 ; year:2015 ; pages:735-753 ; extent:19
EMBO molecular medicine / European Molecular Biology Organization ; 7, Heft 6 (2015), 735-753 (gesamt 19)
- Urheber
-
Duluc, Camille
Moatassim‐Billah, Siham
Chalabi‐Dchar, Mounira
Perraud, Aurélie
Samain, Rémi
Breibach, Florence
Gayral, Marion
Cordelier, Pierre
Delisle, Marie‐Bernadette
Bousquet‐Dubouch, Marie‐Pierre
Tomasini, Richard
Schmid, Herbert
Mathonnet, Muriel
Pyronnet, Stéphane
Martineau, Yvan
Bousquet, Corinne
- DOI
-
10.15252/emmm.201404346
- URN
-
urn:nbn:de:101:1-2022120606310901295051
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:22 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Duluc, Camille
- Moatassim‐Billah, Siham
- Chalabi‐Dchar, Mounira
- Perraud, Aurélie
- Samain, Rémi
- Breibach, Florence
- Gayral, Marion
- Cordelier, Pierre
- Delisle, Marie‐Bernadette
- Bousquet‐Dubouch, Marie‐Pierre
- Tomasini, Richard
- Schmid, Herbert
- Mathonnet, Muriel
- Pyronnet, Stéphane
- Martineau, Yvan
- Bousquet, Corinne
Ähnliche Objekte (12)
Quercetin abrogates chemoresistance in melanoma cells by modulating ΔNp73
mTOR inhibition abrogates human mammary stem cells and early breast cancer progression markers
Blocking Oncostatin M receptor abrogates STAT3 mediated integrin signaling and overcomes chemoresistance in ovarian cancer
LAT2 regulates glutamine-dependent mTOR activation to promote glycolysis and chemoresistance in pancreatic cancer
Metformin abrogates Fusobacterium nucleatum-induced chemoresistance in colorectal cancer by inhibiting miR-361-5p/sonic hedgehog signaling-regulated stemness
Genome editing abrogates angiogenesis in vivo
Snail determines the therapeutic response to mTOR kinase inhibitors by transcriptional repression of 4E-BP1
Hepatic Sirt6 activation abrogates acute liver failure
GLI2 inhibition abrogates human leukemia stem cell dormancy
Mitochondrial dysfunction abrogates dietary lipid processing in enterocytes
4e. Livraison
4e. Livraison
Quercetin abrogates chemoresistance in melanoma cells by modulating ΔNp73
mTOR inhibition abrogates human mammary stem cells and early breast cancer progression markers
Blocking Oncostatin M receptor abrogates STAT3 mediated integrin signaling and overcomes chemoresistance in ovarian cancer
LAT2 regulates glutamine-dependent mTOR activation to promote glycolysis and chemoresistance in pancreatic cancer
Metformin abrogates Fusobacterium nucleatum-induced chemoresistance in colorectal cancer by inhibiting miR-361-5p/sonic hedgehog signaling-regulated stemness
Genome editing abrogates angiogenesis in vivo
Snail determines the therapeutic response to mTOR kinase inhibitors by transcriptional repression of 4E-BP1
Hepatic Sirt6 activation abrogates acute liver failure
GLI2 inhibition abrogates human leukemia stem cell dormancy
Mitochondrial dysfunction abrogates dietary lipid processing in enterocytes
4e. Livraison
4e. Livraison
Quercetin abrogates chemoresistance in melanoma cells by modulating ΔNp73
mTOR inhibition abrogates human mammary stem cells and early breast cancer progression markers
Blocking Oncostatin M receptor abrogates STAT3 mediated integrin signaling and overcomes chemoresistance in ovarian cancer
LAT2 regulates glutamine-dependent mTOR activation to promote glycolysis and chemoresistance in pancreatic cancer
Metformin abrogates Fusobacterium nucleatum-induced chemoresistance in colorectal cancer by inhibiting miR-361-5p/sonic hedgehog signaling-regulated stemness
Genome editing abrogates angiogenesis in vivo
Snail determines the therapeutic response to mTOR kinase inhibitors by transcriptional repression of 4E-BP1
Hepatic Sirt6 activation abrogates acute liver failure
GLI2 inhibition abrogates human leukemia stem cell dormancy
Mitochondrial dysfunction abrogates dietary lipid processing in enterocytes
4e. Livraison